Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.41 % |
3 Month Return | -10.14 % |
1 Year Return | -33.52 % |
Market Stats | |
Previous Close | ₹11.88 |
Open | ₹11.29 |
Volume | 15.02K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹46.12Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹46.12 Cr |
P/B Ratio | 1.41 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹46.12 Cr | 4.15% | 0.58 | NA | NA | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Vista Pharmaceuticals Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Vista Pharmaceuticals Ltd
Vista Pharmaceuticals reported standalone net sales of Rs 1.80 crore for June 2024, a decline of 9.39% year-on-year. The company incurred a net loss of Rs 0.86 crore, compared to a profit of Rs 0.09 crore in the previous year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 107.4%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 78.79% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 92.1%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 21.19% of holdings in Sep 2024 quarter
Price Dip
In the last 1 year, Vista Pharma. stock has moved down by -33.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 21.19% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0.02% | 0.00 | |
Retail Investors | 78.79% | 0.00 | |
Others | 0% | 0.00 |
Vista Pharmaceuticals Ltd’s net profit jumped 51.98% since last year same period to ₹0.97Cr in the Q2 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -12.79% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Vista Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Vista Pharmaceuticals Ltd (524711) share price today is ₹11.34
Vista Pharmaceuticals Ltd is not listed on NSE
Vista Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Vista Pharmaceuticals Ltd(524711) is 15.02K.
Today’s market capitalisation of Vista Pharmaceuticals Ltd(524711) is ₹46.12Cr.
Vista Pharmaceuticals Ltd(524711 | Price |
---|---|
52 Week High | ₹18 |
52 Week Low | ₹10.43 |
Vista Pharmaceuticals Ltd(524711) share price is ₹11.34. It is down -37.00% from its 52 Week High price of ₹18
Vista Pharmaceuticals Ltd(524711) share price is ₹11.34. It is up 8.72% from its 52 Week Low price of ₹10.43
Vista Pharmaceuticals Ltd(524711 | Returns |
---|---|
1 Day Returns | -0.54% |
1 Month Returns | -3.41% |
3 Month Returns | -10.14% |
1 Year Returns | -33.52% |